IRX 211 OPIOID ALTERNATIVE, page-101

No response from anyone because the IRX strategy is absolutely flawed and IMO the company is already looking for another deal. I’m guessing Niv Dagan knows this and he’s a lot smarter than Darryl Davies or Sud Argarwal from what I hear.

IMO the 3 promoters on this thread either don’t understand biotechnology and patent law or they do and are they are deliberately avoiding the key issues because it doesn’t serve their purpose.

There’s no point posting pictures of pelicans pinkeye when you have an opportunity to actually refute my observation.